Aptose Biosciences Files 8-K
Ticker: APTOF · Form: 8-K · Filed: May 5, 2025 · CIK: 882361
Sentiment: neutral
Topics: disclosure, financials
Related Tickers: APTO
TL;DR
APTO filed an 8-K on 5/5/25 for Reg FD & financials. Check it out.
AI Summary
Aptose Biosciences Inc. filed an 8-K on May 5, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Lorus Therapeutics Inc. and Imutec Pharma Inc., is incorporated in Canada and operates in the biological products sector.
Why It Matters
This filing provides important updates on Aptose Biosciences' regulatory and financial disclosures, which are crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and disclosures, not indicating any immediate operational or financial distress.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- Lorus Therapeutics Inc. (company) — Former company name
- Imutec Pharma Inc (company) — Former company name
- May 5, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is Aptose Biosciences Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 5, 2025.
What were Aptose Biosciences Inc.'s former names?
Aptose Biosciences Inc. was formerly known as Lorus Therapeutics Inc. and Imutec Pharma Inc.
In which jurisdiction is Aptose Biosciences Inc. incorporated?
Aptose Biosciences Inc. is incorporated in Canada.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 5, 2025 regarding Aptose Biosciences Inc. (APTOF).